IRIS Accounts Production v26.2.0.496 05756257 Board of Directors 1.4.25 31.3.26 31.3.26 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 1766 1550 1425 1032 1624 4348 1965 1766 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh057562572025-03-31057562572026-03-31057562572025-04-012026-03-31057562572024-03-31057562572024-04-012025-03-31057562572025-03-3105756257ns15:EnglandWales2025-04-012026-03-3105756257ns14:PoundSterling2025-04-012026-03-3105756257ns10:Director12025-04-012026-03-3105756257ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3105756257ns10:SmallEntities2025-04-012026-03-3105756257ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-3105756257ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-3105756257ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3105756257ns10:FullAccounts2025-04-012026-03-3105756257ns10:OrdinaryShareClass12025-04-012026-03-3105756257ns10:OrdinaryShareClass22025-04-012026-03-310575625742ns10:Director22025-03-310575625742ns10:Director22024-03-310575625742ns10:Director22025-04-012026-03-310575625742ns10:Director22024-04-012025-03-310575625742ns10:Director22026-03-310575625742ns10:Director22025-03-3105756257ns5:CurrentFinancialInstruments2026-03-3105756257ns5:CurrentFinancialInstruments2025-03-3105756257ns5:ShareCapital2026-03-3105756257ns5:ShareCapital2025-03-3105756257ns5:RetainedEarningsAccumulatedLosses2026-03-3105756257ns5:RetainedEarningsAccumulatedLosses2025-03-3105756257ns10:RegisteredOffice2025-04-012026-03-3105756257ns5:FurnitureFittings2025-04-012026-03-3105756257ns5:FurnitureFittings2025-03-3105756257ns5:FurnitureFittings2026-03-3105756257ns5:FurnitureFittings2025-03-3105756257ns5:DeferredTaxation2025-03-3105756257ns5:DeferredTaxation2025-04-012026-03-3105756257ns5:DeferredTaxation2026-03-3105756257ns10:OrdinaryShareClass12026-03-3105756257ns10:OrdinaryShareClass22026-03-3105756257ns10:Director22025-04-012026-03-3105756257ns10:Director112025-03-3105756257ns10:Director112024-03-3105756257ns10:Director112025-04-012026-03-3105756257ns10:Director112024-04-012025-03-3105756257ns10:Director112026-03-3105756257ns10:Director112025-03-31
REGISTERED NUMBER: 05756257 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2026

for

Yorkshire Womens Health Ltd

Yorkshire Womens Health Ltd (Registered number: 05756257)






Contents of the Financial Statements
for the Year Ended 31 March 2026




Page

Balance Sheet 1

Notes to the Financial Statements 2


Yorkshire Womens Health Ltd (Registered number: 05756257)

Balance Sheet
31 March 2026

31.3.26 31.3.25
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,289 3,073

CURRENT ASSETS
Investments 5 70,017 64,856
Cash at bank 52,607 45,088
122,624 109,944
CREDITORS
Amounts falling due within one year 6 4,969 6,664
NET CURRENT ASSETS 117,655 103,280
TOTAL ASSETS LESS CURRENT
LIABILITIES

119,944

106,353

PROVISIONS FOR LIABILITIES 7 435 584
NET ASSETS 119,509 105,769

CAPITAL AND RESERVES
Called up share capital 8 101 101
Retained earnings 119,408 105,668
SHAREHOLDERS' FUNDS 119,509 105,769

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 September 2026 and were signed on its behalf by:



Dr K Raychaudhuri - Director


Yorkshire Womens Health Ltd (Registered number: 05756257)

Notes to the Financial Statements
for the Year Ended 31 March 2026

1. STATUTORY INFORMATION

Yorkshire Womens Health Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 05756257

Registered office: C/o Echo Tax, SPACES Manchester
Peter House
Oxford Street
Manchester
M1 5AN

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2025 - 2 ) .

Yorkshire Womens Health Ltd (Registered number: 05756257)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1 April 2025 5,056
Additions 449
Disposals (459 )
At 31 March 2026 5,046
DEPRECIATION
At 1 April 2025 1,983
Charge for year 1,233
Eliminated on disposal (459 )
At 31 March 2026 2,757
NET BOOK VALUE
At 31 March 2026 2,289
At 31 March 2025 3,073

5. CURRENT ASSET INVESTMENTS
31.3.26 31.3.25
£    £   
Unlisted investments 70,017 64,856

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.26 31.3.25
£    £   
Tax 2,395 3,494
Credit card 129 15
Phone finance - 789
Directors' current accounts 1,965 1,766
Accrued expenses 480 600
4,969 6,664

7. PROVISIONS FOR LIABILITIES
31.3.26 31.3.25
£    £   
Deferred tax 435 584

Deferred
tax
£   
Balance at 1 April 2025 584
Utilised during year (149 )
Balance at 31 March 2026 435

Yorkshire Womens Health Ltd (Registered number: 05756257)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.26 31.3.25
value: £    £   
100 Ordinary A £1 100 100
1 Ordinary B £1 1 1
101 101

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2026 and 31 March 2025:

31.3.26 31.3.25
£    £   
Dr K Raychaudhuri and Dr D Raychaudhuri
Balance outstanding at start of year (1,766 ) 1,550
Amounts advanced 1,425 1,032
Amounts repaid (1,624 ) (4,348 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (1,965 ) (1,766 )